ArticleFrontiers in pharmacology2022

Atorvastatin Restores PPARα Inhibition of Lipid Metabolism Disorders by Downregulating miR-21 Expression to Improve Mitochondrial Function and Alleviate Diabetic Nephropathy Progression.

Jiayi Xiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.